|
Volumn 142, Issue 3, 2001, Pages 502-511
|
Challenges of subgroup analyses in multinational clinical trials: Experiences from the MERIT-HF trial
a,b,c,d,e,f,g a,b,c,d,e,f,g a,b,c,d,e,f,g a,b,c,d,e,f,g a,b,c,d,e,f,g a,b,c,d,e,f,g a,b,c,d,e,f,g a,b,c,d,e,f,g a,b,c,d,e,f,g a,b,c,d,e,f,g |
Author keywords
[No Author keywords available]
|
Indexed keywords
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
DISEASE CLASSIFICATION;
EVALUATION;
FEMALE;
FOLLOW UP;
HEART FAILURE;
HOSPITALIZATION;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
META ANALYSIS;
MORTALITY;
OUTCOMES RESEARCH;
PRIORITY JOURNAL;
RISK ASSESSMENT;
STATISTICAL ANALYSIS;
|
EID: 17944379905
PISSN: 00028703
EISSN: None
Source Type: Journal
DOI: 10.1067/mhj.2001.117600 Document Type: Article |
Times cited : (110)
|
References (17)
|